Table 1 Demographic, clinical, and surgical characteristics of the groups
Characteristics | Placebo (n = 15) | Methylprednisolone (n = 15) |
|---|---|---|
Demographics | ||
Age (years) | 68.9 ± 11 | 70.7 ± 7.0 |
Male sex (n) | 13 | 10 |
Body weight (kg) | 81.1 ± 9.0 | 82.5 ± 15.7 |
Height (cm) | 173 ± 7.0 | 176 ± 7.9 |
Comorbidity | ||
Hypertension (n) | 9 | 9 |
Previous heart surgery (n) | 0 | 0 |
Atrial fibrillation/flutter (n) | 1 | 0 |
Serum creatinine (μmol/l) | 89.7 ± 15 | 88.3 ± 20 |
Cardiac status | ||
LVEF, % | 60 ± 4.2 | 61 ± 5.8 |
NYHA | ||
I (n) | 7 | 4 |
II (n) | 4 | 9 |
III (n) | 4 | 2 |
IV (n) | 0 | 0 |
EuroSCORE II, % | 1.8 ± 1.4 | 1.9 ± 1.5 |
Type of surgery | ||
SAVR (n) | 10 | 11 |
CABG + SAVR (n) | 5 | 4 |